India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE: OGN), a U.S.-based women's healthcare company.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in women with varying BMIs.
In the closing of the recent trading day, Organon (OGN) stood at $8.7, denoting a +1.05% move from the preceding trading day.
Organon (OGN) reached $8.61 at the closing of the latest trading day, reflecting a +2.14% change compared to its last close.
Organon and Co. (NYSE: OGN - Get Free Report) has earned a consensus recommendation of "Reduce" from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four res
Organon and Co. (NYSE: OGN - Get Free Report) and Embecta (NASDAQ: EMBC - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon enters into agreement to expand access to a new, first-in-class treatment in certain European countries; builds on cardiovascular portfolio.
Organon and Co. (NYSE: OGN - Get Free Report) saw unusually large options trading on Tuesday. Stock investors acquired 17,794 call options on the stock. This is an increase of 550% compared to the ave
Organon and Co. (NYSE: OGN - Get Free Report) and Ardent Health (NYSE: ARDT - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companie
Organon (OGN) concluded the recent trading session at $7.44, signifying a +2.76% move from its prior day's close.
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in Organon and Co. (NYSE: OGN) by 65.2% during the undefined quarter, according to the company in its most recent 13F filing with the Sec
Gilman Hill Asset Management LLC lessened its holdings in shares of Organon and Co. (NYSE: OGN) by 87.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the latest trading session, Organon (OGN) closed at $6.98, marking a +2.2% move from the previous day.
Squarepoint Ops LLC acquired a new stake in Organon and Co. (NYSE: OGN) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE